Published • loading... • Updated
New drug vidofludimus calcium secures patent to treat progressive...
Summary by Multiple Sclerosis News Today
1 Articles
1 Articles
New drug vidofludimus calcium secures patent to treat progressive...
Immunic Therapeutics will receive a new U.S. patent covering its experimental therapy, vidofludimus calcium, and some related molecules in people with multiple sclerosis (MS). Titled “Treatment of multiple sclerosis comprising DHODH inhibitors,” […] The post New patent covers progressive MS drug for patients in US appeared first on Multiple Sclerosis News Today.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium